共 50 条
- [43] Management of relapsed diffuse large B-cell lymphoma Current Oncology Reports, 2008, 10 : 393 - 403
- [44] Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact Reply LANCET HAEMATOLOGY, 2020, 7 (10): : E707 - E708
- [45] Glofitamab in Relapsed Refractory Diffuse Large B-Cell Lymphoma: Single Center Experience CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S445 - S445
- [46] Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma FRONTIERS IN ONCOLOGY, 2021, 11
- [47] Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma FRONTIERS IN ONCOLOGY, 2024, 14
- [49] Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma European Journal of Clinical Pharmacology, 2022, 78 : 707 - 719
- [50] Dose Response of Bulky Tumors in Relapsed/Refractory Diffuse Large B-Cell Lymphoma INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S134 - S135